These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 32486364)

  • 21. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review.
    Alhalaili B; Popescu IN; Kamoun O; Alzubi F; Alawadhia S; Vidu R
    Sensors (Basel); 2020 Nov; 20(22):. PubMed ID: 33218097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.
    Rahman A; Roy KJ; Deb GK; Ha T; Rahman S; Aktar MK; Ali MI; Kafi MA; Choi JW
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 vaccines and nanomedicine.
    Shapiro RS
    Int J Dermatol; 2021 Sep; 60(9):1047-1052. PubMed ID: 34089534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
    Hassanzadeh P
    J Control Release; 2020 Dec; 328():112-126. PubMed ID: 32882269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoagent-based theranostic strategies against human coronaviruses.
    Feng T; Nie C; Peng P; Lu H; Wang T; Li P; Huang W
    Nano Res; 2022; 15(4):3323-3337. PubMed ID: 35003529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
    He C; Qin M; Sun X
    Acta Pharm Sin B; 2020 Jul; 10(7):1175-1191. PubMed ID: 32834948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?
    Uskoković V
    Nanomedicine (Lond); 2020 Jul; 15(17):1719-1734. PubMed ID: 32462968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine strategies to target coronavirus.
    Heinrich MA; Martina B; Prakash J
    Nano Today; 2020 Dec; 35():100961. PubMed ID: 32904707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano-based approaches in the development of antiviral agents and vaccines.
    Li Y; Xiao Y; Chen Y; Huang K
    Life Sci; 2021 Jan; 265():118761. PubMed ID: 33189824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patents Related to Pathogenic Human Coronaviruses.
    Dos Santos M; Ferreira AVF; da Silva JO; Nogueira LM; Machado JM; Francisco MFC; da Paz MC; Giunchetti RC; Galdino AS
    Recent Pat Biotechnol; 2021; 15(1):12-24. PubMed ID: 33504319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-generation treatments: Immunotherapy and advanced therapies for COVID-19.
    Arevalo-Romero JA; Chingaté-López SM; Camacho BA; Alméciga-Díaz CJ; Ramirez-Segura CA
    Heliyon; 2024 Mar; 10(5):e26423. PubMed ID: 38434363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral Activity of Nanomaterials against Coronaviruses.
    Muhammad W; Zhai Z; Gao C
    Macromol Biosci; 2020 Oct; 20(10):e2000196. PubMed ID: 32783352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.